Fatal Prescription

"A true story of unchecked lust, betrayal and murder" - cover.

Now available in hardcover! BEWARE OF THIS FAMILY DOCTOR . . . HE MAY HIRE SOMEONE TO KILL YOU . . . and the medical authorities may not stop him in time! "Talk about abusing a sacred trust! This guy makes other infamous doctors look like choirboys!" reader Glenna B. "Extraordinary ... a remarkable story," Leeza Gibbons, NBC-TV. This stunning new Kindle true crime edition includes an eight-page photo section, index and numerous 2020 updates. An English couple move to North America, but the better life they dream of is shattered when their daughters unsuspectingly complain about sexual misconduct by their family physician. The doctor, a black belt karate expert previously suspended for coercing an underage patient to marry him, now openly tells his young bride he will silence the Simmonds sisters to prevent their testimony because it threatens to shut down his practice. "I will kill them both!" he warns. Dare his terrified young wife and office manager come forward - or will his unwitting patients keep seeing him while the medical board procrastinates? "Reads with the pace of a taut thriller," George Henderson, Gloucester Citizen; "Grippingly told ... a wonderful, powerful book," David Berner, Radio CKNW Vancouver; "Mesmerizing," Bob Stall, Vancouver Province

Deadly Plague There seems to be little connection between the viral devastation of a small African village and the massacre at a drug research facility in Belgium… But Mack Bolan has learned the hard way that appearances can be deceiving. In fact, a wealthy industrialist is about to expand the release of a highly contagious virus out of Africa and into the States, and use the "miracle" antidote as his ticket to the US presidency. It's up to the Executioner to take down the villain's mysterious assassin and stop the pending epidemic…

The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use of cannabis. These landmark changes in policy have impacted cannabis use patterns and perceived levels of risk. However, despite this changing landscape, evidence regarding the short- and long-term health effects of cannabis use remains elusive. While a myriad of studies have examined cannabis use in all its various forms, often these research conclusions are not appropriately synthesized, translated for, or communicated to policy makers, health care providers, state health officials, or other stakeholders who have been charged with influencing and enacting policies, procedures, and laws related to cannabis use. Unlike other controlled substances such as alcohol or tobacco, no accepted standards for safe use or appropriate dose are available to help guide individuals as they make choices regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively. Shifting public sentiment, conflicting and impeded scientific research, and legislative battles have fueled the debate about what, if any, harms or benefits can be attributed to the use of cannabis or its derivatives, and this lack of aggregated knowledge has broad public health implications. The Health Effects of Cannabis and Cannabinoids provides a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis. This report provides a research agendaâ€"outlining gaps in current knowledge and opportunities for providing additional insight into these issuesâ€"that summarizes and prioritizes pressing research needs.

Experts estimate that as many as 98,000 people die in any given year from medical errors that occur in hospitals. That's more than die from motor vehicle accidents, breast cancer, or AIDSâ€"three causes that receive far more public attention. Indeed, more people die annually from medication errors than from workplace injuries. Add the financial cost to the human tragedy, and medical error easily rises to the top ranks of urgent, widespread public problems. To Err Is Human breaks the silence that has surrounded medical errors and their consequenceâ€"but not by pointing fingers at caring health care professionals who make honest mistakes. After all, to err is human. Instead, this book sets forth a national agendaâ€"with state and local implicationsâ€"for reducing medical errors and improving patient safety through the design of a safer health system. This volume reveals the often startling statistics of medical error and the disparity between the incidence of error and public perception of it, given many patients' expectations that the medical profession always performs perfectly. A careful examination is made of how the surrounding forces of legislation, regulation, and market activity influence the quality of care provided by health care organizations and then looks at their handling of medical mistakes. Using a detailed case study, the book reviews the current understanding of why these mistakes happen. A key theme is that legitimate liability concerns discourage reporting of errorsâ€"which begs the question, "How can we learn from our mistakes?" Balancing regulatory versus market-based initiatives and public versus private efforts, the Institute of Medicine presents wide-ranging recommendations for improving patient safety, in the areas of leadership, improved data collection and analysis, and development of effective systems at the level of direct patient care. To Err Is Human asserts that the problem is not bad people in health careâ€"it is that good people are working in bad systems that need to be made safer. Comprehensive and straightforward, this book offers a clear prescription for raising the level of patient safety in American health care. It also explains how patients themselves can influence the quality of care that they receive once they check into the hospital. This book will be vitally important to federal, state, and local health policy makers and regulators, health professional licensing officials, hospital administrators, medical educators and students, health caregivers, health journalists, patient advocatesâ€"as well as patients themselves. First in a series of publications from the Quality of Health Care in America, a project initiated by the Institute of Medicine

What happens when the race to stop a lethal bacteria becomes a race to stop a killer? Dr. Sara Miles’ teenage patient is on the brink of death from an overwhelming, highly resistant infection with Staph luciferus, known to doctors as “the killer.” Only an experimental antibiotic, developed and administered by Sara’s ex-husband can save the girl's life. But potentially lethal effects from the drug send Sara and her colleague, Dr. Rip Pearson, on a hunt for hidden critical data that will let them reverse the effects before it’s too late. What is the missing puzzle piece? And who is hiding it? "Lethal Remedy boasts a gripping medical plot that only an insider could write so believably... Dr. Mabry takes his knowledge of the medical profession, combines it with a ticking clock, and gives the reader a problem we'd all be terrified to face. What more could the reader of a good medical suspense ask for?" —Susan Sleeman, author of Behind The Badge and The Justice Agency series "Lethal Remedy is the perfect cure for boredom: a first-rate medical thriller with humor, engaging characters, and realism that only a seasoned doctor could bring to the story." --Rick Acker, author of When the Devil Whistles and Blood Brothers